| Non-Small Cell Lung Cancer |
1 |
1 |
| Biologic Therapy |
0 |
0.9 |
| Lung Cancer |
0 |
0.95 |
| Small Cell Lung Cancer |
0 |
0.56 |
| Antibody Drug Conjugates |
0 |
0.99 |
| Lung Metastases |
0 |
0.53 |
| Breast Cancer |
0 |
0.52 |
| Cancer |
0 |
0.46 |
| Hodgkin Lymphoma |
0 |
0.46 |
| Tumor |
0 |
0.46 |
| Lung |
0 |
0.4 |
| Antineoplastic Drug |
0 |
0.39 |
| Metastasis |
0 |
0.39 |
| Triple Negative Breast Cancer |
0 |
0.38 |
| Interstitial Lung Disease |
0 |
0.37 |
| Head and Neck Cancer |
0 |
0.36 |
| Brain Metastasis |
0 |
0.35 |
| Advanced and Metastatic Breast Cancer |
0 |
0.33 |
| Genomic Medicine |
0 |
0.29 |
| Toxicology |
0 |
0.29 |
| Antigens |
0 |
0.2 |
| Tyrosine Kinase Inhibitor |
0 |
0.19 |
| Anemia |
0 |
0.13 |
| Breast |
0 |
0.13 |
| Clinical Research |
0 |
0.13 |
| Tyrosine Kinase |
0 |
0.13 |
| Healthcare and Medical Technology |
0 |
0.12 |
| Brain |
0 |
0.07 |
| Chemotherapy |
0 |
0.07 |
| Fatigue |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| Humanized Monoclonal Antibody |
0 |
0.07 |
| Immunotherapy |
0 |
0.07 |
| Nausea |
0 |
0.07 |
| Pharmacogenomics |
0 |
0.07 |
| Platinum |
0 |
0.07 |
| Diarrhea |
0 |
0.06 |